Tradeoffs

A handful of states allow terminally ill people to take life-ending medications prescribed by a doctor instead of waiting for death. This week, we talk with journalist Steven Petrow about his sister’s choice to use medical aid in dying.Guest:Steven Petrow, Journalist and author Learn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

Companies claim they can catch cancer sooner with new blood tests and full-body MRI scans. What are the risks and benefits?Guest: Ishani Ganguli, MD, MPH, Assistant Professor of Medicine, Harvard Medical School; primary care physician, Brigham and Women's HospitalLearn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

A live conversation between a top federal health official and a health care executive about how they must work together to keep AI from exacerbating racial bias in health care.Guests:Micky Tripathi, PhD, MPP, National Coordinator for Health Information Technology, U.S. Department of Health and Human ServicesJames Ellzy, MD, Chief Health Officer, Oracle Health Government ServicesLearn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

Key court decisions in 2024 about prescription drug prices, abortion bans, gender affirming care and the Affordable Care Act could change the way health care is delivered in America. Guests:Zach Baron, Co-director of Health Policy and the Law Initiative, O’Neill Institute for National and Global Health at Georgetown University Law CenterKatie Eyer, Professor at Rutgers Law School Laurie Sobel, Associate Director of Women's Health Policy at KFF Learn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

Fentanyl killed 75,000 people in 2022. Now it’s making one of the few treatments for opioid addiction harder to use.Guests:Eric Ezzi, Certified Recovery Specialist, Penn MedicineAshish Thakrar, MD, Assistant Professor of Medicine, University of PennsylvaniaLeslie Suen, MD, Assistant Professor of Medicine, University of California San FranciscoRyan Levi, Reporter/Producer, Tradeoffs Learn more and read a full transcript on our website.Subscribe to our weekly newsletter.Follow us on X, LinkedIn and Youtube. Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

We've got a lot to share with you in 2024!We're looking into how fentanyl and other synthetic opioids are upending long established treatments for opioid addiction, and what clinicians and policymakers are doing to adapt.There are a bunch of cases in the courts this year that have the potential to change Americans' access to care, and restrict the power of federal health agencies.And nearly 25 years after a landmark case, declaring that people with intellectual and developmental disabilities have a right to live outside state-run institutions, we examine how doctors, hospitals and insurers are failing many of them … and one woman's work to forge a better path.New episodes start 25 January, 2024!Sign up for our weekly newsletter.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

Last fall, the federal government named its first 10 targets for historic drug price negotiations with big pharma. Those negotiations are expected to heat up this February when federal officials make their opening price offers.This week, we offer a refresher on how this negotiation process will work and the impact it could have.Guests:Anton Avanceña, PhD, Assistant Professor of Health Outcomes, University of Texas Darius Lakdawalla, PhD, Professor of Pharmaceutical Economics and Public Policy, University of Southern California Lauren Neves, JD, Deputy Vice President, PhRMASteve Pearson, MD, MSc, Founder and President, Institute for Clinical and Economic Review (ICER)Ben Rome, MD, MPH, physician and researcher, Harvard Medical SchoolMeena Seshamani, MD, PhD, Deputy Administrator, Centers for Medicare and Medicaid ServicesLeslie Walker, Senior Producer/Reporter, TradeoffsLearn more and read a full transcript on our website.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

More than 130 hospitals have closed in rural America over the last decade. Reporter Sarah Jane Tribble spent a year embedded in one small Kansas town as they dealt with their own hospital closure.Guest: Sarah Jane Tribble, Senior Correspondent, Kaiser Health NewsRead a transcript of this conversation: https://tradeoffs.org/2020/10/08/losing-a-hospital/Hear more of Sarah Jane's reporting about Fort Scott on the first season of Where It Hurts: whereithurts.show Hosted on Acast. See acast.com/privacy for more information.

From where medical students are choosing to train to how doctors are caring for women in reproductive health crises, the Supreme Court's decision to overturn Roe has had major ripple effects on the field of medicine. In this conversation from our friends at STAT's First Opinion podcast, host Torie Bosch talks with two abortion providers about what it's like to practice medicine in post-Roe America.Learn more and read a full transcript on our website.Support this type of journalism today, with a gift, which for a limited time will be matched! Hosted on Acast. See acast.com/privacy for more information.

Economist Amy Finkelstein has studied America’s patchwork of health insurance policies for more than 20 years. In a forthcoming book she concludes it’s time tear the whole system down.This week, Dan talks with Amy about how she came to that conclusion and what a better system could look like. Guest:Amy Finkelstein, PhD, Professor of Economics, MITLearn more and read a full transcript on our website.Support this type of journalism today, with a gift, which for a limited time will be matched! Hosted on Acast. See acast.com/privacy for more information.